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The Role of Interleukin-6 in UVA Protection against
UVB-Induced Immunosuppression
Vivienne E. Reeve1, Rex M. Tyrrell2, Munif Allanson1, Diane Domanski1 and Lynette Blyth1
The proinflammatory cytokine IL-6 is released in the skin following UVB irradiation, but its potential for
photoimmune modulation remains unclear. This study utilizes IL-6-deficient mice to demonstrate that IL-6 does
not contribute to the normal contact hypersensitivity response, nor to its systemic suppression by UVB
radiation or cis-urocanic acid. In contrast, IL-6 was required for the attenuation of UVB- or cis-urocanic acid-
induced immunosuppression by sequential or concomitant UVA irradiation. The IL-6 was essential for several
reactions previously established to be relevant for UVA photoimmune protection, namely the induction of
heme oxygenase-1 (HO-1), the activity of its product carbon monoxide in activating guanylyl cyclase, and the
consequent elevation of cutaneous cyclic guanosine monophosphate concentration. In addition, IL-6-deficient
mouse skin had an elevated constitutive overexpression of HO activity, apparently not associated with
photoimmune protection. This suggested that both the cutaneous level of HO activity, and the receptiveness of
the HO-1 gene to stressors like UVA, normally controlled by promoter-binding repressor proteins, may also be
under IL-6 control. Thus IL-6 has an important photoimmune protective function through interaction at several
levels in the pathway determining the immunologically advantageous actions of UVA radiation. This may
constitute a valuable endogenous antiphotocarcinogenic regulatory mechanism.
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INTRODUCTION
It has been shown that the UVB waveband (290–320 nm)
suppresses T cell-mediated immunity both locally and
systemically in mice and humans, and that the photoimmu-
nosuppressed state appears to be a prerequisite for photo-
carcinogenesis in mice and humans (Fisher and Kripke, 1982;
Czarnecki et al., 1995). Studies of the mechanisms under-
lying the induction of this immunosuppressed state have
identified both UVB-induced epidermal DNA damage, and
UVB-induced formation of cis-urocanic acid in the skin, as
mediators (Ullrich, 2005). It is also understood that photo-
immune suppression is associated with an imbalance in the
cutaneous cytokine array, such that the Th2 cytokines IL-4
and IL-10 predominate, and expression of the immune
potentiating Th1 cytokines IL-12 and IFN-g is diminished or
absent (Ullrich, 2005). Other cytokines that are associated
with inflammatory responses, such as IL-6 and tumor-necrosis
factor-a are also altered by UV irradiation, but have been less
well studied in relation to photoimmune suppression.
Although tumor-necrosis factor-a contributes to the migratory
efflux of epidermal dendritic cells, the infiltration of dermal
mast cells following UV irradiation, and to local photo-
immune suppression (Moodycliffe et al., 1994; Shimizu and
Streilein, 1994; Hart et al., 1998), it remains unclear whether
this cytokine is involved in systemic photoimmune suppres-
sion (Amerio et al., 2001), and much less is known about
such a function for IL-6.
An advantageous immunological interaction between the
UVB and the longer wavelength UVA (320–400nm) wave-
bands has recently been described in detail in the mouse, and
has support from data in humans (Sjovall and Christensen,
1986; Skov et al., 2000). In mice, it has been demonstrated
that UVA-induced immunoprotection against the suppressive
effects of UVB depends on the induction of the redox-
regulated stress protein heme oxygenase-1 (HO-1) in the skin
(Reeve and Tyrrell, 1999). The enzymatic product of HO,
gaseous carbon monoxide (CO) initiates a signaling cascade
by the activation of soluble guanylyl cyclase to elevate the
levels of cyclic guanosine monophosphate (cGMP) in the
skin. Immune protection by UVA radiation against the
suppressive effect of UVB has been found to correlate with
elevated cutaneous cGMP (Allanson et al., 2006). In previous
studies, treatment of mice with the substrate antagonist of HO
enzyme activity, tin protoporphyrin-IX, or with a CO-
releasing molecule (CO-RM) applied topically, have respec-
tively inhibited, or mimicked, the immunoprotective effect
of UVA exposure (Reeve and Tyrrell, 1999; Allanson and
Reeve, 2005).
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A relationship between HO-1 or CO, and the cutaneous
cytokine pattern, remains unclear, although it has been
demonstrated that at least IFN-g is required for UVA
photoimmune protection (Reeve et al., 1999). In extracuta-
neous tissues, activity of the pleiotropic cytokine IL-6 has
been reported to be modulated by HO activation (Tamion
et al., 1999) or CO exposure (Song et al., 2003). However, IL-
6 appears to be associated more directly with HO-1 gene
activity. An IL-6-responsive element of the human HO-1 gene
in liver cells and vascular endothelial cells has been
indicated (Mitani et al., 1992; Lavrosky et al., 1996),
consistent with subsequent evidence of HO-1 induction by
IL-6 in human macrophages (Ricchetti et al., 2004), coronary
endothelial cells (Deramaudt et al., 1999), corneal epithelial
cells (Neil et al., 1995), and liver cells (Fukuda and Sassa,
1994; Tron et al., 2006), whereas the skin remains untested.
The pleiotropic nature of IL-6 is shown by its actions in both
proinflammatory and antiinflammatory ways. IL-6 is a key
mediator in various inflammatory processes by which tissues
respond to injury and infection, both in the acute-phase
reaction or in chronic inflammatory diseases (Rose-John et al.,
2006), and is believed to govern the resolution of acute innate
immunity and to steer the transition to an acquired immune
response. There are known interactions between IL-6 signaling
and many regulatory factors (IFN-g, transforming growth
factor-b, transcription factors STAT3, NF-kB) that have been
implicated in the resolution of acute inflammation, but also the
prolongation of chronic inflammation (Jones, 2005). In the
skin, epidermal IL-6 is critical for healthy wound healing,
which is impaired in IL-6/ mice (Gallucci et al., 2000), but
skin tumors (melanoma and basal-cell carcinoma) are reported
to overexpress IL-6, resulting in inhibited apoptosis, increased
cyclooxygenase activity and elevated intracellular cAMP
levels (Jee et al., 2001; Kast, 2007). The pleiotropic actions
of IL-6 may have relevance in the contradictory conditions of
the inflammatory skin erythema reaction to UV radiation, that
is accompanied by immune suppression and expression of
antiinflammatory cytokines.
Thus the photoimmunological function of IL-6 is unclear,
although IL-6 has been reported to be increased in mouse
serum, human plasma, human keratinocytes, and pterygium
epithelial cells following UVB irradiation (Urbanski et al.,
1990; Nishimura et al., 1999; Di Girolamo et al., 2002; Fagot
et al., 2002). On the other hand, its UVB-induced expression
in mouse skin (Reeve et al., 2006) and normal human
keratinocytes (Petit-Frere et al., 1998; Clingen et al., 2001)
was reported to be decreased by concurrent or subsequent
UVA irradiation. In this study therefore we have probed the
contributing actions of IL-6 to the photoimmune suppressed
state, and its possible function in photoimmune protection by
UVA, making use of the IL-6 deficient mouse (‘‘IL-6/’’) in
comparison with the normal wild-type C57BL/6 (‘‘C57’’)
mouse.
RESULTS
IL-6 is not involved in photoimmune suppression
The contact hypersensitivity (CHS) reaction in the IL-6/
mice appeared to be normal. The average ear swellings in
mice that had received no other treatment or only application
of base lotion were found to be not significantly different from
the wild-type C57 mice (Figure 1). The suppressed response
(32% suppression) to the SSUV irradiation was also not
significantly altered by the absence of IL-6, compared
with C57 mice (29% suppression), and this was supported
by the unaltered suppression by topical cis-urocanic
acid (34% suppression) compared with the C57 mice
(36% suppression). Interestingly, the irritant reaction in the
negative control mice receiving only the challenge treatment
of oxazolone (no sensitization) was negligible (not signifi-
cantly different from untreated mice) in the C57 mice, but
was greater and significant (Po0.01) in the IL-6/ mice.
Photoimmune protection by UVA is compromised in
IL-6/ mice
The capacity for UVA radiation to affect the degree of
immunosuppression resulting from a subsequent exposure to
UVB, or topical application of cis-urocanic acid, was tested.
In this experiment the normal CHS reaction in the IL-6/
mice was slightly but statistically significantly (Po0.001)
reduced by 18% compared with the wild-type C57 mice
(Figure 2). However UVA irradiation was innocuous in both
mouse strains, and the suppression of CHS by UVB
irradiation (41% in IL-6/ and 40% in C57 mice) and by
topical cis-urocanic acid (37 and 44%) was similar. In
accordance with the previously established immunoprotec-
tive effect of UVA radiation, this degree of suppressed CHS
was markedly (Po0.001) reduced in the C57 mice when
UVA irradiation preceded the UVB or cis-urocanic acid
treatment, resulting in only 19 and 22% suppression,
respectively. In contrast, the UVA irradiation before UVB or
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Figure 1. Contact hypersensitivity and photoimmune suppression are
normal in IL-6/ mice. Contact hypersensitivity reaction to oxazolone,
measured as average ear swelling, in groups of 5 IL-6/ and 5 C57 mice
irradiated with 3 1 MEdD of SSUV (or NIL), or treated topically with cis-
urocanic acid (or BASE lotion). The negative control mice (ve CON) were
not sensitized but received only oxazolone challenge on the ears. Error
bars¼ SEM. *Indicates significant difference between treatments.
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cis-urocanic acid treatment in the IL-6/ mice did not
prevent the immunosuppression, and these mice remained 38
and 49% immunosuppressed. The combined treatment of
UVA followed by cis-urocanic acid in the IL-6/ mice even
slightly but statistically significantly exacerbated the degree
of immunosuppression due to cis-urocanic acid alone
(Po0.01).
When the UVA and UVB wavebands were administered
concurrently as SSUV radiation (Figure 3; UVA and UVB at
240V; UVA/UVB ratio 19.1), there was a similar degree of
suppression of CHS in both C57 and IL-6/ mice (29 and
26% suppression, respectively). Enrichment of this radiation
3.5-fold with UVA by dimming the UVB source (UVA at
240V, UVB at 156V; UVA/UVB ratio 62.1), but maintaining
the same total UVB dose, totally reversed the immunosup-
pression in the C57 mice (5% suppression, not significantly
different from unirradiated mice). In contrast, UVA enrich-
ment did not protect the IL-6/ mice from the suppression
of CHS, but instead significantly exacerbated the immune
defect (54% suppression; Po0.001).
Heme oxygenase activity is elevated in IL-6/ mice, but
noninducible by UVA radiation
Failure of UVA to afford photoimmune protection in the
absence of IL-6 suggested that HO-1 induction may have
been inhibited, therefore HO enzyme activity was assayed in
microsomal suspensions from the skin and liver of IL-6/
and C57 mice. The result indicated that there was an
approximately threefold increase in the constitutive enzyme
activity in the skin of unirradiated IL-6/ mice compared
with C57 mice (11.8 compared with 3.6 pmol per mg protein
per min, respectively; Table 1). Furthermore, liver HO
activity was also elevated approximately twofold in the IL-
6/ mouse (Table 1). To support the altered constitutive
HO enzyme activities, levels of the enzyme substrate, heme,
and the product, bilirubin, were also assayed in skin extracts.
Heme concentration in the IL-6/ mouse skin was
significantly reduced by approximately 50% compared with
C57 mice, whereas bilirubin concentration was increased
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Figure 2. Photoimmune protection by UVA is abrogated in IL-6/ mice.
Contact hypersensitivity reaction to oxazolone, measured as average ear
swelling, in groups of 5 IL-6/ and 5 C57 mice without other treatments
(NIL), or following irradiation with 400 kJm2 of UVA or 1 3 MEdD of UVB,
or topical treatment with cis-urocanic acid, alone or preceded by an exposure
of 400 kJm2 of UVA. Error bars¼ SEM; symbols indicate significant
differences between treatments.
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Figure 3. Photoimmune protection by UVA-enriched radiation is abrogated
in IL-6/ mice. Contact hypersensitivity reaction to oxazolone, measured
as average ear swelling, in groups of 5 IL-6/ and 5 C57 mice without other
treatments (NIL), or following irradiation with SSUV (UVB at 240V; UVA/
UVB ratio 19.1) or with UVA-enriched radiation (UVB at 156V; UVA/UVB
ratio 62.1) providing the same UVB dose. Error bars¼ SEM; *indicates
significant difference between treatments.
Table 1. Average microsomal HO enzyme activity in
the skin and liver of IL-6/ and C57 mice (n=5),
before and at 72 h following UVA irradiation
Skin Liver
Mouse NIL UVA NIL UVA
IL-6/ 11.79±2.14 6.95±2.27 57.92±2.60 60.04±6.65
C57 3.62±1.96* 10.18±1.55* 31.7±2.78** 49.36±1.98**
Matching symbols indicate significantly differing values. HO enzyme
activity (pmol bilirubin per mg protein per min±SEM).
*,**Po0.01.
Table 2. Average microsomal heme and cutaneous
bilirubin levels±SEM in the skin of untreated IL-6/
and C57 mice (n=3)
Mouse [Heme] [Bilirubin]
IL-6/ 3.1±0.14 mgmg1 protein* 0.581±0.273 pmol g1 skin**
C57 6.3±0.17* 0.165±0.057**
Matching symbols indicate significantly differing values.
*Po0.01; **Po0.001.
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approximately 3.5-fold (Table 2), consistent with the
observed elevated HO activity in IL-6/ mice.
As anticipated, UVA irradiation resulted in significant
(Po0.01) increases in HO enzyme activity in the skin and the
liver of C57 mice (Table 1). However, UVA did not induce
HO activity in either the skin or the liver of the IL-6/mice.
Instead, the cutaneous HO activity appeared to be reduced
by UVA by approximately 30% (11.8–7.0 pmol per mg
protein per min), although this was not statistically signi-
ficant, but the hepatic HO activity remained approximately
the same (60.0 pmol per mg protein per min) as in the
unirradiated IL-6/ mice (57.9 pmol per mg protein per
min).
Overall, the constitutively elevated HO activity detected
in the unirradiated IL-6/ mouse tissues was of a similar
level as the UVA-induced HO activity in the C57 mouse skin
(11.8 and 10.2 pmol bilirubin per mg protein per min,
respectively) and the liver (57.9 and 49.4 pmol bilirubin per
mg protein per min, respectively. Despite this, the immune
response to UVA irradiation had been observed to differ
significantly.
CO-RM is not immunoprotective against cis-urocanic acid in
IL-6/ mice
The lack of UVA photoimmune protection in spite of the
elevated constitutive HO activity in the IL-6/ mouse
suggested that downstream targets of the HO enzyme
products might be unresponsive. Therefore the capacity of
CO to mediate photoimmune protection was assessed by
treating mice topically with a CO-RM. In C57 mice, cis-
urocanic acid induced 36% suppression of CHS, and this was
effectively decreased by the topical treatment with the CO-
RM, resulting in only 6% suppression (Figure 4). In contrast,
CO-RM application did not protect against cis-urocanic acid
immunosuppression in the IL-6/ mice, and the 46%
suppression of CHS caused by the cis-urocanic acid was not
significantly altered by the CO-RM treatments, and remained
at 51% immunosuppression. Therefore, an IL-6 dependence
for the CO-mediated activation of downstream targets of HO
was identified.
Cutaneous cGMP level is unresponsive to UVA radiation in
IL-6/ mice
Because CO-RM has been shown to acquire its photoimmune
protective properties by activating guanylyl cyclase in the
skin (Allanson et al., 2006), the product of this enzyme,
cGMP was assayed in untreated and UVA-irradiated mice
(Figure 5). The constitutive cutaneous cGMP levels were not
statistically significantly different in C57 and IL-6/ skin. As
anticipated, UVA irradiation significantly (Po0.05) increased
the cGMP level in the C57 mouse, from 3.59 to
8.41 pmol g1 skin. In contrast, UVA failed to significantly
alter the cGMP level in the IL-6/ mouse skin
(2.15–2.84 pmol g1 skin). Therefore an IL-6 dependence for
the production of the photoimmune protective elevated
cGMP level in the skin was identified.
DISCUSSION
The normal CHS reaction of IL-6/ mice demonstrated in
these studies is in contrast to previous evidence suggesting
that this cytokine deficiency markedly inhibited the CHS
reaction (Nishimura et al., 1999). In the earlier report, in
which mice were sensitized similarly with either oxazolone
or DNFB, the mice were not housed in isolation from other
mice, which may have predisposed them to subclinical or
mild pathogenic infections, compromising their cell-
mediated immunological capacity. A second report of
reduced CHS responsiveness to oxazolone in IL-6/ mice
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Figure 4. Photoimmune protection by topical CO-RM fails in IL-6/ mice.
Contact hypersensitivity reaction to oxazolone, measured as average ear
swelling, in groups of 5 IL-6/ and 5 C57 mice without other treatments
(NIL), or following topical treatment with a CO-RM, and its effect on the
immunosuppression induced by topical cis-urocanic acid treatment. Error
bars¼ SEM; *indicates significant difference between treatments.
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Figure 5. UVA fails to induce cutaneous CGMP in IL-6/ mice. Average
levels of cGMP assayed in the skin of IL-6/ and C57 mice (n¼3), before
and at 48 hours after irradiation with 400 kJm2 of UVA.Error bars¼ SEM.
*Indicates significant difference between treatments.
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also has indicated that the mice were not housed under
barrier conditions (Hope et al., 2000). In contrast, the delayed
type hypersensitivity reaction induced by footpad injection of
myelin oligodendrocyte glycoprotein in IL-6/ mice was
found to be reduced by approximately 60% compared to the
wild-type reaction even when the mice were housed in
specific pathogen-free conditions (Okuda et al., 1998). It is
thus apparent that the effects of the mouse housing
conditions, or the sensitizing antigen or its route of
administration, are not well understood at this point.
However, under the more stringent housing conditions of
the current study, IL-6/ mice responded normally to the
contact sensitizer, with the exception of a slight decrease by
18% in the normal CHS of the IL-6/ mice in one
experiment, which we interpret as a minor failure of the
housing isolation. Nevertheless, even in this case, there was
no difference between IL-6/ and C57 mice in the degree
of suppression of CHS by either SSUV, UVB or the UVB
suppressive mediator, cis-urocanic acid. This is consistent
with the report of no further significant suppression of CHS by
UVB radiation in the nonisolated IL-6/ mice in the earlier
study, even though the constitutive CHS reaction was
inhibited (Nishimura et al., 1999). Therefore it appears that
IL-6 is not essential for the CHS reaction, nor is this cytokine
active in the suppression of cell-mediated immunity by UVB
radiation.
Unexpectedly, it was found that there was a small but
significant primary irritant reaction to oxazolone in the
negative control ‘‘challenge-only’’ C57 mice, whereas
IL-6/ mouse ears did not swell significantly. Similar
reactions have been reported by others in greater detail
(Hope et al., 2000), in mice that were not barrier-protected.
We suggest that IL-6 is required for the production of a
primary inflammatory reaction in the skin, and would
contribute to the UVB-induced erythema, but may have no
function in the ensuing immune dysregulation by either
environment or UVB. We speculate that, in keeping with its
pleiotropic functions, UVB-induced IL-6 may then also have
a function in the resolution of the erythema inflammation,
which would be consistent with the prolonged skin damage
and failure of wound healing in IL-6 deficiency.
The mechanism of the inflammatory resolution, that would
also protect the immune system, could be the UVB-produced
IL-6 facilitating the UVA activation of the HO-1 pathway.
However it is not clear how cis-urocanic acid would be
involved. In unpublished experiments we have been unable
to detect IL-6 protein expression in response to cis-urocanic
acid treatment in the hairless mouse, consistent with an early
study in cultured human keratinocyte culture supernatant
(Redondo et al., 1996), but in contrast to a recent report that
cis-urocanic acid dose-dependently upregulated the expres-
sion at both the gene and protein levels, of several cytokines
including IL-6 in human keratinocytes (Kaneko et al., 2008).
Clearly a better understanding of the possible link between
cis-urocanic acid and cutaneous cytokines is needed.
On the other hand, an important function for IL-6 was
identified in the immune protective interaction between the
UVA waveband and immunosuppressive UVB radiation. The
IL-6/ mouse was immunologically unresponsive to both
UVA irradiation before an immunosuppressive exposure to
UVB or topically applied cis-urocanic acid, and to UVA
enrichment of combined UVA/UVB radiation. The known
involvement of HO-1 activity in UVA photoimmune protec-
tion suggested that HO-1 might not be induced as normal by
UVA in IL-6 deficiency. A lack of HO inducibility by UVA
radiation was confirmed at the level of HO enzyme activity in
the IL-6/ mouse skin. The defective inducibility of HO
activity was also detected in the mouse liver, indicating a
systemic requirement for IL-6 in both the skin and extra-
cutaneous tissues, for effective responses to UVA or the
oxidative stress it produces. In a study by others, IL-6/
mice were found also to be more susceptible to hydrogen
peroxide-induced oxidative stress, consistent with an im-
paired HO-1 inducibility (Kida et al., 2005).
Interestingly, the IL-6/ mouse skin and liver constitu-
tively overexpressed HO enzyme activity in comparison with
the normal C57 mouse. A similar overexpression had been
reported in the IFN-g/ mouse (Reeve et al., 1999). This
overactivity was consistent with the reduced heme level and
increased bilirubin level in the IL-6/ skin, but did not
provide the photoimmune protection for which UVA-induced
HO-1 is recognized. The inducibility of the HO-1 gene
therefore seems to be the critical reaction from which the
immunological modulation stems, rather than the mainte-
nance of an elevated enzyme activity. It may be relevant that
a refractoriness of upregulated HO-1 to repeated oxidative
stimuli, including UVA irradiation, has been observed both in
cultured human skin fibroblasts and in the photoimmune
protection by UVA radiation in hairless mice (Noel and
Tyrrell, 1997; Reeve and Domanski, 2002). Although the
mechanism of such refractoriness has not been fully
characterized, it probably involves the activity of the
promoter-binding regulatory proteins that maintain the
normal repressed but receptive state of the HO-1 gene. We
speculate that this regulation of the HO-1 gene by the
repressor proteins might also be IL-6 dependent.
We have not yet examined whether UVA radiation
upregulates IL-6 in the mouse skin, however it does not
seem likely as we and others have observed that UVA inhibits
the UVB induction of epidermal IL-6, and a partial action
spectrum by others has attributed IL-6 induction in human
keratinocytes to UVB wavelengths below 313nm (Petit-Frere
et al., 1998). Nevertheless, there is conflicting in vitro data
showing UVA induction of both HO-1 and IL-6 in cultured
human skin fibroblasts by singlet oxygen production (Ober-
muller-Jevic et al., 2001), and UVA induction of IL-6 in
human keratinocytes and dermal fibroblasts (Avalos-Diaz
et al., 1999). Further studies should seek to extend these
observations to the in vivo model.
The topical administration of CO-RM has been previously
shown to mimic the photoimmune protection of UVA
radiation. However, CO-RM was ineffectual in IL-6/ mice
against cis-urocanic acid-induced immune suppression,
identifying an additional function for IL-6 in facilitating the
activation by CO of its target(s) in the skin. It is consistent that
CO has been reported to be inactive also in mice in which
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serum IL-6 levels were decreased by deletion of the c-Jun
N-terminal kinase pathway (Morse et al., 2003).
As guanylyl cyclase has been shown to be a major
immunological target for the HO product CO, the IL-6
dependence of its enzyme product cGMP was tested. The
results implicate IL-6 as an essential factor in the formation of
cutaneous cGMP, as this important second signaling mole-
cule was not increased by the UVA irradiation of the IL-6/
mouse skin. The tissue level of cGMP is determined by the
balance of its synthesis by guanylyl cyclase and its normal
degradation by the cellular phosphodiesterases. Therefore,
either guanylyl cyclase activity is IL-6 dependent, consistent
with the immunological inactivity of the CO-RM in IL-6
deficiency, and with reports indicating a positive correlation
between IL-6 and cGMP levels in neural or lung tissue (Ma
and Zhu, 1996; Mabuchi et al., 2002), or phosphodiesterase
activity is normally inhibited by IL-6. Future studies should
shed light on possible cytokine regulation of these enzyme
activities.
These data lead to the overall conclusion that the
pleiotropic cytokine IL-6, although reported by us and others
to be released following UVB irradiation, does not appear to
be active in the induction of photoimmune suppression, but
rather to contribute to the inflammation of the sunburn
reaction. Instead, a requirement for IL-6 in the skin has been
identified in several reactions activated by UVA exposure that
are relevant for the photoimmune protective effect of this
waveband, namely the induction of HO-1, the activity of its
product CO, and the formation of cGMP. We conclude that
the phenomenon of photoimmune protection by UVA
radiation, achieved via this redox-regulated pathway, is IL-6
dependent.
MATERIALS AND METHODS
Mice
Normal female inbred C57BL/6 (‘‘C57’’) mice and outbred female
mice with a targeted mutation for the cytokine IL-6 (Il6tm1Kopf,
‘‘IL-6/’’) that have been backcrossed to C7BL/6, were obtained
from the Veterinary Science breeding colony. The IL-6/ colony
was developed from the original mutant created by Kopf et al. (1994)
by homologous recombination disrupting the IL-6 gene, and is
maintained by homozygous matings. Homozygous IL-6/mice are
viable and fertile and maintain good health when housed in stress-
free isolated conditions. They have been reported to have defective
responses to various viruses, and abnormal inflammatory responses
to tissue damage or infection (Kopf et al., 1994).
Mice entered the studies at 9–12 weeks of age. The IL-6/ mice
were housed in a closed ventilated caging system, and the C57 mice
were housed in the same room in conventional wire-topped open
cages. The bedding was compressed paper (Fibrecycle Pty. Ltd.,
Mudgeeraba, Queensland, Australia), ambient temperature was
25 1C, and the room lighting was from GEC F40 GO gold fluorescent
tubes that do not emit UV radiation, on a 12 hours on/off cycle. The
mice were fed standard rodent pellets (Gordons Specialty Stock-
feeds, Yanderra, NSW, Australia) and tapwater ad libitum. The study
was performed under the approval of the University of Sydney
Animal Ethics Committee, and conforms to the current Animal
Welfare Act of New South Wales.
UV radiation
The radiation sources were made up of seven 120-cm fluorescent
tubes held in a reflective batten 19 cm above the irradiation table
surface. Irradiance was measured using an International Light IL1500
radiometer (International Light Inc., Newburyport, MA) with UVA
and UVB detectors (SEE 015/UVA and SEE 240/UVB) calibrated to
the spectral irradiance of the source. The solar simulated UV (SSUV)
radiation source comprised two banks of 3 UVA tubes (Hitachi 40W
F40T10BL, Tokyo, Japan) flanking a single UVB tube (Philips TL-
40W/12 RS, Eindhoven, the Netherlands), with the radiation filtered
through a sheet of 0.125mm cellulose acetate (Grafix Plastics,
Cleveland, OH) to block contaminating wavelengths below 290 nm.
This SSUV source provided 3.45 103Wcm2 UVA and
1.94 104Wcm2 UVB. Switching off selected tubes enabled us
to isolate the UVB (filtered through cellulose acetate) or UVA
wavebands (filtered through 6mm window glass). Furthermore,
attenuating the voltage supply to the UVB tube alone (from 240 to
156V) using a rheostat, whereas retaining 240V supply to the UVA
tubes, enabled us to increase the UVA/UVB ratio from 19.1 to 62.1,
resulting in an enrichment of approximately 3.5-fold of the UVA
component, while administering a constant UVB component to the
mice, as previously described (Reeve et al., 2006; Ibuki et al., 2007).
Groups of 3–5 mice were clipped of dorsal fur (Oster clippers;
Oster Manufacturing, Milwaukee, WI) 24 hours before irradiation.
They were irradiated unrestrained with the cage tops removed. SSUV
was administered on 3 consecutive days as a daily minimal
edematous dose (MEdD), previously determined from the increase
in the middorsal skinfold thickness at 24 hours to be 45.0 kJm2
UVA and 2.52 kJm2 UVB in the shaved C57 mouse (Cho et al.,
2008). When UVB was administered alone, this was a single
exposure of 1 3 MEdD (7.56 kJm2 UVB) which resulted in a
moderate but nonburning edematous reaction. These doses, whether
given as 3 1 MEdD or 1 3 MEdD, are established immunosup-
pressive doses in these mice. Administration of UVA alone was as a
single exposure of 400 kJm2 UVA, a subedematous dose, estab-
lished as immunologically innocuous (Reeve and Tyrrell, 1999). To
observe the effect of UVA enrichment of concurrent UVA and UVB,
the radiation was administered as 1 3 MEdD of SSUV (UVB at
240V) or as UVA-enriched UVA/UVB radiation (UVB at 156V) in a
single exposure providing the same UVB content (7.56 kJm2 UVB)
but with 3.49-fold increased UVA (from 135 to 471 kJm2 UVA).
This UVA-enriched radiation source mimics the effect of prolonged
sunlight exposure by humans through a UVB-blocking topical
sunscreen.
Treatment of mice with cis-urocanic acid
In some experiments, the mice were treated with topical application
of the immunosuppressive mediator, cis-urocanic acid. The
cis isomer was produced by UVB irradiation of a thin layer of a
4% solution of trans-urocanic acid (Sigma-Aldrich Corp., Castle Hill,
NSW, Australia) in DMSO, resulting in an equilibrium mixture of
approximately 50% of each isomer, referred to as ‘‘cis-urocanic
acid’’ here, that was diluted into a simple cosmetic oil-in-water
emulsion to provide 0.2% urocanic acids and 5% DMSO, as
previously described (Allanson and Reeve, 2005). Aliquots of 0.1ml
(0.2mg urocanic acids) were applied to the mouse dorsum on 3
consecutive days (comparison with 3 1 MEdD of SSUV), or 3 times
within 24hours (comparison with single exposures of UVA or UVB).
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This daily dose of urocanic acid applied approximates urocanic acid
content extracted from hairless mouse skin (Ley, Reeve and Kusewitt,
2000; 6.6 mg cm2 of skin, x approximately 30 cm2 dorsal skin area,
or 0.198mg per mouse dorsum).
Treatment of mice with CO
The compound tricarbonyldichlororuthenium (II) dimer ([Ru(CO)3Cl2]2;
Sigma-Aldrich), known as a ‘‘carbon monoxide-releasing molecule’’,
or CO-RM, releases gaseous CO when in DMSO solution (Allanson
and Reeve, 2005). The CO-RM was freshly solubilized at 0.5mM in a
10% DMSO/lotion vehicle and 0.2ml aliquots immediately applied
to the shaved mouse dorsum daily for days 1–3. The control
treatment was with 0.2ml of the 10% DMSO/lotion vehicle only.
When combined with cis-urocanic acid treatments, the CO-RM
application preceded the cis-urocanic acid by 1 hour. CHS was
induced with oxazolone on the abdomen on days 8, 9, as described
below.
Induction of contact hypersensitivity
For the measurement of CHS, groups of 5 shaved C57 or IL-6/
mice were UV irradiated on the dorsum (or remained nonirradiated),
or were treated topically with cis-urocanic acid lotion, or the
DMSO-base lotion only. At 1 week later the mice were sensitized on
the untreated abdominal skin with 0.1ml 2% oxazolone (Sigma-
Aldrich) in ethanol, as previously described in greater detail (Reeve
and Tyrrell, 1999), in order to detect systemic changes in immune
response. The mice were challenged a further week later by
application of 5 ml 2% oxazolone to each surface of both pinnae.
The maximum degree of ear swelling, measured with a spring
micrometer (Interrapid, Zurich, Switzerland) was obtained from
repeated two hourly measurements between 18 and 24 hours later
(most commonly at 20 hours after challenge), and gave the measure
of immune responsiveness. No temporal differences in the develop-
ment of the peak ear swelling or its resolution were apparent
between the mouse strains. The group average ear swelling at the
peak time point, and the percentage suppression of the reaction by
the dorsal treatments, were calculated for both mouse strains.
Statistical significance of the differences between treatment groups
was obtained using Student’s t-test.
Assay of cutaneous heme oxygenase enzyme activity, heme and
bilirubin
Microsomal suspensions were prepared from homogenates of C57
and IL-6/middorsal skin, and liver for the HO assay, taken before
and at 72 hours post-UVA irradiation. The HO enzyme activity and
the heme level were measured as previously described, quantitated
by microsomal protein concentration (Allanson and Reeve, 2004).
Bilirubin was extracted into chloroform from whole skin homo-
genates of both mouse strains before and at 72 hours post-UVA
irradiation and analyzed spectrophotometrically as previously
described, quantitated by wet weight of skin (Allanson and Reeve,
2004).
Assay of cutaneous cGMP
Cutaneous cGMP was extracted from dorsal skin samples from three
mice before and at 48 hours post-UVA irradiation and quantitated
per wet weight of skin using a commercial ELISA kit (R&D Systems,
Minneapolis, MO) as previously described (Allanson et al., 2006).
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